DEXMEDETOMIDINE KABI 100 micrograms/ml, concentrate for solution for infusion 10 bottles of 2 ml
Active ingredients: Dexmedetomidine hydrochloride, Dexmedetomidine
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Concentrate for solution for infusion10 bottles of 2 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DEXMEDETOMIDINE KABI 100 microgrammes/mL, solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 10 flacons en verre de 2 mL
- Marketing authorisation holder
- FRESENIUS KABI FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Oct 2023
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68657230CIP75508321CIP133400955083214Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE DEXMÉDÉTOMIDINEsolution | — | SA |
| DEXMÉDÉTOMIDINEsolution | 100 microgrammes · 1 mL de solution | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.